State Of Wyoming Avid Bioservices, Inc. Transaction History

State Of Wyoming

$592 Million
Q2 2024

A detailed history of State Of Wyoming transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, State Of Wyoming holds 3,600 shares of CDMO stock, worth $40,968. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,600

Previous 3,333 8.01%

Holding current value

$40,968

Previous $22,000 13.64%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.34 - $9.28 $1,692 - $2,477	267 Added 8.01%	3,600 $25,000
Q1 2024 May 13, 2024	SELL	$5.86 - $8.79 $14,087 - $21,131	-2,404 Reduced 41.9%	3,333 $22,000
Q4 2023 Feb 14, 2024	SELL	$4.64 - $9.56 $2,672 - $5,506	-576 Reduced 9.12%	5,737 $37,000
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $23,020 - $34,383	2,449 Added 63.38%	6,313 $59,000
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $12,947 - $20,909	999 Added 34.87%	3,864 $53,000
Q1 2023 May 12, 2023	BUY	$13.48 - $18.79 $1,873 - $2,611	139 Added 5.1%	2,865 $53,000
Q4 2022 Feb 14, 2023	SELL	$12.61 - $18.74 $30,881 - $45,894	-2,449 Reduced 47.32%	2,726 $37,000
Q3 2022 Nov 14, 2022	BUY	$15.33 - $20.36 $41,222 - $54,748	2,689 Added 108.17%	5,175 $99,000
Q2 2022 Aug 15, 2022	SELL	$11.63 - $21.55 $57,661 - $106,844	-4,958 Reduced 66.6%	2,486 $38,000
Q1 2022 May 13, 2022	BUY	$16.63 - $27.73 $6,685 - $11,147	402 Added 5.71%	7,444 $152,000
Q4 2021 Feb 11, 2022	BUY	$20.7 - $34.18 $4,533 - $7,485	219 Added 3.21%	7,042 $205,000
Q3 2021 Feb 11, 2022	SELL	$19.05 - $28.32 $28,060 - $41,715	-1,473 Reduced 17.76%	6,823 $147,000
Q2 2021 Feb 11, 2022	BUY	$18.93 - $25.65 $157,043 - $212,792	8,296 New	8,296 $213,000

Others Institutions Holding CDMO

# of Institutions

181

Shares Held

65M

Call Options Held

21.3K

Put Options Held

110K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $707M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account